Core Viewpoint - The company plans to invest 20 million RMB in Shanghai Renyan Information Technology Co., Ltd. to acquire a 6.67% stake, aiming to enhance its strategic transformation and develop a second growth curve focused on AI-enabled grassroots healthcare [2][4][12]. Group 1: Investment Overview - The investment will be made using the company's own funds, with the corresponding increase in registered capital for Renyan Information being 241,476 RMB [2][4]. - After the investment, the company's total registered capital in Renyan Information will amount to 3,622,135 RMB [3][10]. Group 2: Financial Data of Renyan Information - As of June 30, 2025, Renyan Information reported total assets of 392.85 million RMB and total liabilities of 229.42 million RMB, resulting in a net asset value of 163.42 million RMB [8]. - The company's operating revenue for the first half of 2025 was 482.30 million RMB, with a net profit attributable to the parent company of 29.72 million RMB [8]. Group 3: Rationale for the Investment - The investment is expected to facilitate the integration of external resources to build a collaborative ecosystem for grassroots healthcare services, potentially opening new business growth avenues [12][13]. - The collaboration aims to address core pain points in community hospitals and create a closed-loop treatment process, enhancing operational efficiency [12][14]. Group 4: Approval Process - The investment has been approved by the company's board of directors and independent directors, confirming that it adheres to fair market principles and does not harm the interests of shareholders, especially minority shareholders [14]. - The transaction does not require shareholder approval as it falls within the board's authority [14].